Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study
Presented at the 19th Annual Meeting of the Society for Pediatric and Perinatal Epidemiology, Seattle, WA, June 20-21, 2006.
Received 2 April 2007; received in revised form 20 July 2007; accepted 13 October 2007. published online 28 January 2008.
Objective
The objective of the study was to examine whether the risk of miscarriage is associated with caffeine consumption during pregnancy after controlling for pregnancy-related symptoms.
Study Design
This was a population-based prospective cohort study.
Results
An increasing dose of daily caffeine intake during pregnancy was associated with an increased risk of miscarriage, compared with no caffeine intake, with an adjusted hazard ratio (aHR) of 1.42 (95% confidence interval 0.93 to 2.15) for caffeine intake of less than 200 mg/day, and aHR of 2.23 (1.34 to 3.69) for intake of 200 or more mg/day, respectively. Nausea or vomiting during pregnancy did not materially affect this observed association, nor did the change in intake pattern of caffeine during pregnancy. In addition, the magnitude of the association appeared to be stronger among women without a history of miscarriage (aHR 2.33, 1.48 to 3.67) than that among women with such a history (aHR 0.81, 0.34 to 1.94).
Conclusion
Our results demonstrated that high doses of caffeine intake during pregnancy increase the risk of miscarriage, independent of pregnancy-related symptoms.
Division of Research, Kaiser Permanente, Oakland, CA.
Reprints: Dr. De-Kun Li, Division of Research, Kaiser Foundation Research Institute, Kaiser Permanente, 2000 Broadway, Oakland, CA 94612.
This study was supported in part by the California Public Health Foundation.
Cite this article as: Weng X, Odouli R, and Li D-K. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008;198:279.e1-279.e8.